Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Epigenetic Reprogramming of Radiation Fibrosis using Adipose Derived Stromal Cells

FY 2015-16

Summary
Radiation fibrosis effects up to 70% of patients who have had radiation treatment. This irreversible and progressive condition begins months to years after treatment. It causes tissue firmness, pain, and distortion, which reduces the quality of life of cancer survivors. Despite this, the exact mechanisms which promote and sustain radiation fibrosis are not known. Recent evidence has shown that epigenetic changes, alterations to gene activity without changes in DNA sequence, may have a strong role in the development of radiation fibrosis. This study proposes to use a novel cell-based approach to treat radiation fibrosis by reversing these epigenetic changes. As cancer survivorship increases, so too will the number of patients with side effects from cancer therapy. By reversing radiation fibrosis using a novel cell-based therapy, we hope to improve the functional capacity of patients with radiation fibrosis, so that ultimately these cancer survivors may live with an improved quality of life.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
339774
Name
Zhao Xiao
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Epigenetic Reprogramming of Radiation Fibrosis using Adipose Derived Stromal Cells
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Adipose Derived Stromal Cells; Cancer Survivorship; Epigenetic Reprogramming; Radiation Fibrosis; Regenerative Medicine
Abstract
Radiation fibrosis effects up to 70% of patients who have had radiation treatment. This irreversible and progressive condition begins months to years after treatment. It causes tissue firmness, pain, and distortion, which reduces the quality of life of cancer survivors. Despite this, the exact mechanisms which promote and sustain radiation fibrosis are not known. Recent evidence has shown that epigenetic changes, alterations to gene activity without changes in DNA sequence, may have a strong role in the development of radiation fibrosis. This study proposes to use a novel cell-based approach to treat radiation fibrosis by reversing these epigenetic changes. As cancer survivorship increases, so too will the number of patients with side effects from cancer therapy. By reversing radiation fibrosis using a novel cell-based therapy, we hope to improve the functional capacity of patients with radiation fibrosis, so that ultimately these cancer survivors may live with an improved quality of life.
Competitiondate
201511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Zhao, Xiao
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
University of Toronto - $150,000 Grant (2015-16) | Canada Spends